Apellis Pharmaceuticals Inc (APLS)
47.49
+1.44
(+3.13%)
USD |
NASDAQ |
May 02, 16:00
46.72
-0.77
(-1.62%)
Pre-Market: 08:53
Apellis Pharmaceuticals Cash from Operations (Quarterly): -97.88M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -97.88M |
| September 30, 2023 | -169.08M |
| June 30, 2023 | -150.16M |
| March 31, 2023 | -177.62M |
| December 31, 2022 | -140.74M |
| September 30, 2022 | -154.42M |
| June 30, 2022 | -107.02M |
| March 31, 2022 | -111.56M |
| December 31, 2021 | -112.50M |
| September 30, 2021 | -168.62M |
| June 30, 2021 | -128.69M |
| March 31, 2021 | -153.31M |
| December 31, 2020 | 141.98M |
| September 30, 2020 | -99.82M |
| Date | Value |
|---|---|
| June 30, 2020 | -94.29M |
| March 31, 2020 | -108.35M |
| December 31, 2019 | -82.07M |
| September 30, 2019 | -53.60M |
| June 30, 2019 | -39.91M |
| March 31, 2019 | -35.56M |
| December 31, 2018 | -44.48M |
| September 30, 2018 | -33.13M |
| June 30, 2018 | -30.69M |
| March 31, 2018 | -22.94M |
| December 31, 2017 | -15.53M |
| September 30, 2017 | -11.14M |
| June 30, 2017 | -11.50M |
| March 31, 2017 | -8.427M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-177.62M
Minimum
Mar 2023
141.98M
Maximum
Dec 2020
-105.67M
Average
-111.56M
Median
Mar 2022
Cash from Operations (Quarterly) Benchmarks
| Sarepta Therapeutics Inc | -242.08M |
| Blueprint Medicines Corp | -78.93M |
| Alnylam Pharmaceuticals Inc | -29.80M |
| Ionis Pharmaceuticals Inc | 32.86M |
| Madrigal Pharmaceuticals Inc | -79.93M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 0.004M |
| Cash from Financing (Quarterly) | -3.913M |
| Free Cash Flow | -595.51M |
| Free Cash Flow Per Share (Quarterly) | -0.8081 |
| Free Cash Flow to Equity (Quarterly) | -98.05M |
| Free Cash Flow to Firm (Quarterly) | -95.07M |
| Free Cash Flow Yield | -10.57% |